What Do Family Physicians Think of Colorectal Cancer Screening?

Abstract

What Do Family Physicians Think of Colorectal Cancer Screening?

Abstract

Purpose: The purpose of this study was to evaluate family physician (FP) practice in terms of CRC screening and recommendations for increasing participation in screening programs. Methods: The population in this descriptive study, conducted between 15 June and 15 July, 2019, consisted of 325 (78.9%) FPs working in Samsun, Turkey and consenting to participate. A questionnaire prepared by the authors based on the relevant literature was applied at face-to-face interviews. Results: The mean age of the FPs was 44.6±0.4 years, and their mean time in service was 19.7±0.54 years. The most common suggestions were “having a dedicated member of staff of cancer screenings in family health centers”, “public education”, and “reducing the numbers of patients registered with FPs”. FPs most frequently thought that “public education”, “health education on the social media and TV”, and “reminders issued to patients” might be effective in increasing CRC screening. The methods they regarded as having the least effect were “pamphlets”, “reminder leaflets”, and “informative texts in newspapers”. Conclusions: Screening programs should be carried out in a multidisciplinary manner, including not only physicians but also other health professionals such as health educators, with a team-based approach.

Keywords

• colorectal cancer
• screening
• family physician
• primary health care

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71(3):209-49.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34.
3. World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity, and the prevention of cancer: A global perspective 2018. (cited 3.07.2022). Available from URL: https://www.wcrf.org/wp-content/uploads/2021/02/Summary-of-Third-Expert-Report-2018.pdf.
4. Ministry of Health of the Republic of Turkey. Turkey Cancer Statistics 2017. 2021. (cited 3.07.2022). Available from URL: https://ghdx.healthdata.org/record/turkey-health-statistics-yearbook-2017
5. Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ 2015;351:h4970.
6. Altobelli E, Lattanzi A, Paduano R, Varassi G, di Orio F. Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med 2014;62:132-41.
7. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467.
8. Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer 2015;121(13):2281-5.

9. Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut. 2015;64(5):784-90.
10. Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, et al. Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst 2017;109(8).
11. Ebell MH, Thai TN, Royalty KJ. Cancer screening recommendations: an international comparison of high income countries. Public Health Rev 2018;39:7.
12. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2019;69(3):184-210.
13. Sabatino SA, White MC, Thompson TD, Klabunde CN, Centers for Disease C, Prevention. Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(17):464-8.
14. Ministry of Health of the Republic of Turkey. Turkey Cancer Control Program 2016. (cited 3.07.2022). Available from URL: https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/yayinlar/Kitaplar/TURKIYE_KANSER_KONTROL_PROGRAMI_2016.pdf.
15. CDC Behavioral Risk Factor Surveillance System. Use of Colorectal Cancer Screening Tests 2020. (cited 3.07.2022). Available from URL: https://www.cdc.gov/cancer/colorectal/statistics/use-screening-tests-BRFSS.htm.
16. Brown T, Lee JY, Park J, Nelson CA, McBurnie MA, Liss DT, et al. Colorectal cancer screening at community health centers: A survey of clinicians' attitudes, practices, and perceived barriers. Prev Med Rep 2015;2:886-91.
17. Demyati E. Knowledge, Attitude, Practice, and Perceived Barriers of Colorectal Cancer Screening among Family Physicians in National Guard Health Affairs, Riyadh. Int J Family Med 2014;2014:457354.
18. Dressler J, Johnsen AT, Madsen LJ, Rasmussen M, Jorgensen LN. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review. Public Health 2021;190:67-74.
19. Muliira JK, D'Souza MS, Ahmed SM. Contrasts in Practices and Perceived Barriers to Colorectal Cancer Screening by Nurses and Physicians Working in Primary Care Settings in Oman. J Cancer Educ 2016;31(1):15-25.
20. Omran S, Barakat H, Muliira JK, Aljadaa N. Knowledge, experiences, and barriers to colorectal cancer screening: a survey of health care providers working in primary care settings. J Cancer Educ 2015;30(1):53-61.
21. Power E, Wardle J. Change in public awareness of symptoms and perceived barriers to seeing a doctor following Be Clear on Cancer campaigns in England. Br J Cancer 2015;112 Suppl 1:S22-6.
22. Rosenwasser LA, McCall-Hosenfeld JS, Weisman CS, Hillemeier MM, Perry AN, Chuang CH. Barriers to colorectal cancer screening among women in rural central Pennsylvania: primary care physicians' perspective. Rural Remote Health 2013;13(4):2504.
23. Wang H, Roy S, Kim J, Farazi PA, Siahpush M, Su D. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health 2019;19(3):5181.
24. Wong CR, Bloomfield ER, Crookes DM, Jandorf L. Barriers and facilitators to adherence to screening colonoscopy among African-Americans: a mixed-methods analysis. J Cancer Educ 2013;28(4):722-8.
25. Brandenbarg D, Roorda C, Groenhof F, Havenga K, Berger MY, de Bock GH, et al. Increased primary health care use in the first year after colorectal cancer diagnosis. Scand J Prim Health Care 2014;32(2):55-61.
26. Arcuri R, Bulhões B, Jatobá A, Bellas HC, et al. Gatekeeper family doctors operating a decentralized referral prioritization system: Uncovering improvements in system resilience through a grounded-based approach. Safety Science 2020;121:177-190.
27. Basch CH, Basch CE, Wolf RL, Zybert P. Motivating factors associated with receipt of asymptomatic colonoscopy screening. Int J Prev Med 2015;6:20.
28. Federici A, Giorgi Rossi P, Bartolozzi F, Farchi S, Borgia P, Guasticchi G. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy. Prev Med 2005;41(1):30-5.
29. Norwati D, Harmy MY, Norhayati MN, Amry AR. Colorectal cancer screening practices of primary care providers: results of a national survey in Malaysia. Asian Pac J Cancer Prev 2014;15(6):2901-4.
30. Jones RM, Woolf SH, Cunningham TD, Johnson RE, Krist AH, Rothemich SF, et al. The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med 2010;38(5):499-507.
31. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005;41(1):23-9.
32. Berg-Beckhoff G, Leppin A, Nielsen JB. Reasons for participation and non-participation in colorectal cancer screening. Public Health. 2022;205:83-9.
33. Zhu X, Weiser E, Jacobson DJ, Griffin JM, Limburg PJ, Finney Rutten LJ. Provider-perceived barriers to patient adherence to colorectal cancer screening. Prev Med Rep 2022;25:101681.
34. Aytepe UE, Dönmez E. Türkiye’de Kolorektal Kanser Tarama Davranışları, Etkileyen Faktörler ve Taramaya Katılmama Nedenleri: Sistematik Derleme. Halk Sağlığı Hemşireliği Dergisi 2022;4(1):56-76.
35. Collins C, Homeniuk R. How many general practice consultations occur in Ireland annually? Cross-sectional data from a survey of general practices. BMC Family Practice 2021;22(1):1-9.
36. Statista. Number of patients that physicians in the U.S. saw per day from 2012 to 2018. (cited 05.10.2023). Available from URL:https://www.statista.com/statistics/613959/us-physicans-patients-seen-per-day/
37. Statista. Median number of patients seen during a typical workweek by primary care physicians in Canada in 2019. (cited 05.10.2023). Available from URL: https://www.statista.com/statistics/1097220/median-number-of-patients-seen-weekly-by-primary-physicians-by-jurisdiction-canada/
38. Porter J, Boyd C, Skandari MR, Laiteerapong N. Revisiting the time needed to provide adult primary care. Journal Of General Internal Medicine 2023;38(1):147-155.